We are live on ! Find out more
Corient Private Wealth

Corient Private Wealth Portfolio holdings

AUM $69.9B
1-Year Est. Return 22.19%
This Fund
S&P 500
This Quarter Est. Return
+9.83%
1 Year Est. Return
+22.19%
3 Year Est. Return
+69.97%
5 Year Est. Return
10 Year Est. Return
AUM
$56.2B
AUM Growth
+$1.8B
Cap. Flow
+$5.21B
Cap. Flow %
9.28%
Top 10 Hldgs %
21.35%
Holding
2,399
New
146
Increased
921
Reduced
1,050
Closed
123

Sector Composition

Rank Sector Weight
1 Technology 19.64%
2 Healthcare 11.07%
3 Financials 10.51%
4 Industrials 7.72%
5 Consumer Discretionary 7.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PEP icon
26
PepsiCo
PEP
$186B
$440M 0.78%
2,513,122
-9,920
-0.4% -$1.67M
ACN icon
27
Accenture
ACN
$89.9B
$415M 0.74%
1,196,499
+22,562
+2% +$8.22M
CVX icon
28
Chevron
CVX
$388B
$411M 0.73%
2,606,271
-35,038
-1% -$5.29M
META icon
29
Meta Platforms (Facebook)
META
$1.51T
$390M 0.69%
803,411
+6,041
+0.8% +$2.69M
XOM icon
30
ExxonMobil
XOM
$651B
$389M 0.69%
3,346,998
-109,832
-3% -$11.5M
ABBV icon
31
AbbVie
ABBV
$458B
$385M 0.69%
2,114,576
-66,316
-3% -$11.4M
SYK icon
32
Stryker
SYK
$127B
$374M 0.67%
1,047,353
+4,681
+0.4% +$1.57M
MCD icon
33
McDonald's
MCD
$188B
$354M 0.63%
1,256,074
-26,543
-2% -$7.72M
ZTS icon
34
Zoetis
ZTS
$31.6B
$332M 0.59%
1,960,734
+7,226
+0.4% +$1.35M
DHR icon
35
Danaher
DHR
$135B
$314M 0.56%
1,259,250
+30,934
+3% +$7.55M
VWO icon
36
Vanguard FTSE Emerging Markets ETF
VWO
$119B
$303M 0.54%
7,259,035
+855,891
+13% +$34.9M
PCAR icon
37
PACCAR
PCAR
$69.6B
$287M 0.51%
2,318,835
-97,791
-4% -$10.5M
BSV icon
38
Vanguard Short-Term Bond ETF
BSV
$44.6B
$282M 0.5%
3,682,155
+307,878
+9% +$23.6M
ABT icon
39
Abbott
ABT
$180B
$272M 0.48%
2,391,309
-58,219
-2% -$6.67M
CAT icon
40
Caterpillar
CAT
$409B
$267M 0.47%
727,454
-16,178
-2% -$5.17M
IWF icon
41
iShares Russell 1000 Growth ETF
IWF
$122B
$263M 0.47%
3,123,912
-59,404
-2% -$4.79M
VTI icon
42
Vanguard Total Stock Market ETF
VTI
$654B
$259M 0.46%
995,756
+59,366
+6% +$14.7M
MA icon
43
Mastercard
MA
$477B
$257M 0.46%
533,826
-7,081
-1% -$3.24M
AXP icon
44
American Express
AXP
$223B
$254M 0.45%
1,114,710
-63,377
-5% -$13.1M
LIN icon
45
Linde
LIN
$237B
$251M 0.45%
542,765
+4,627
+0.9% +$2M
LRCX icon
46
Lam Research
LRCX
$382B
$244M 0.43%
2,513,460
-11,580
-0.5% -$1.02M
TJX icon
47
TJX Companies
TJX
$170B
$238M 0.42%
2,346,552
+269,915
+13% +$26.2M
SBUX icon
48
Starbucks
SBUX
$118B
$236M 0.42%
2,585,967
+3,960
+0.2% +$368K
SPGI icon
49
S&P Global
SPGI
$126B
$233M 0.42%
547,762
+79,626
+17% +$34.5M
VBK icon
50
Vanguard Small-Cap Growth ETF
VBK
$23.2B
$232M 0.41%
888,616
+7,325
+0.8% +$1.8M

Similar funds

Corient Private Wealth's Q1 2024 Portfolio in Review

As of Q1 2024, Corient Private Wealth held 2,399 positions worth $56.2B, up 3.3% from $54.4B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Corient Private Wealth deployed $5.21B of net new capital in Q1 2024, opening 146 new positions and adding to 921 existing holdings. Its largest new stake was iShares iBonds Dec 2028 Term Corporate ETF: 693,322 shares worth $17.3M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Apple, an estimated $165M trimmed.

  • Corient Private Wealth's largest Q1 2024 buy was iShares iBonds Dec 2028 Term Corporate ETF: 693,322 shares worth $17.3M.
  • Corient Private Wealth added most to Berkshire Hathaway Class A in Q1 2024, an estimated $5.82B increase.
  • Corient Private Wealth's biggest Q1 2024 reduction was Apple, cutting an estimated $165M.
  • Corient Private Wealth fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $21.7M.
  • Corient Private Wealth's ten largest holdings make up 21% of its $56.2B portfolio in Q1 2024.
  • Corient Private Wealth opened 146 new positions and closed 123 in Q1 2024.
  • Corient Private Wealth's portfolio value rose 3.3% quarter-over-quarter to $56.2B.

Based on Corient Private Wealth's 13F filing for Q1 2024, filed 9 May 2024.